Get started
HYPHENS PHARMAHYPHENS PHARMAHYPHENS PHARMA

HYPHENS PHARMA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

1J5 chart


Full chart

1J5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪88.12 M‬ SGD
Dividend yield (indicated)
5.26%
Price to earnings Ratio (TTM)
8.635
Basic EPS (TTM)
0.035 SGD
Net income (FY)
‪10.19 M‬ SGD
Revenue (FY)
‪195.42 M‬ SGD
Shares float
‪56.83 M‬
Beta (1Y)
0.32

Employees


Employees (FY)
474
Change (1Y)
+34 +7.73%
Revenue / Employee (1Y)
‪412.28 K‬ SGD
Net income / Employee (1Y)
‪21.51 K‬ SGD

About HYPHENS PHARMA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
See Wah Lim
Website
hyphensgroup.com
Headquarters
Singapore
Founded
1998
ISIN
SG1EE4000006
FIGI
BBG00KSQBRM1
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of pharmaceutical and consumer healthcare products. It operates through the following segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital. The Specialty Pharma Principals segment includes marketing and selling specialty pharmaceutical products. The Proprietary Brands segment is involved in the development, distribution, and sale of its own proprietary range of dermatological products and health supplement products. The Medical Hypermart and Digital segment focuses on the wholesale of pharmaceuticals and medical supplies. The company was founded by See Wah Lim in 1998 and is headquartered in Singapore.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1J5 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 1J5.

Frequently Asked Questions


The current price of 1J5 is 0.285 SGD — it has increased by 1.75% in the past 24 hours. Watch HYPHENS PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SGX exchange HYPHENS PHARMA stocks are traded under the ticker 1J5.
1J5 stock has risen by 5.45% compared to the previous week, the month change is a 1.75% rise, over the last year HYPHENS PHARMA has showed a 3.64% increase.
We've gathered analysts' opinions on HYPHENS PHARMA future price: according to them, 1J5 price has a max estimate of 0.35 SGD and a min estimate of 0.35 SGD. Watch 1J5 chart and read a more detailed HYPHENS PHARMA stock forecast: see what analysts think of HYPHENS PHARMA and suggest that you do with its stocks.
1J5 reached its all-time high on Jul 21, 2020 with the price of 0.625 SGD, and its all-time low was 0.160 SGD and was reached on Feb 4, 2019. View more price dynamics on 1J5 chart.
See other stocks reaching their highest and lowest prices.
1J5 stock is 1.75% volatile and has beta coefficient of 0.32. Track HYPHENS PHARMA stock price on the chart and check out the list of the most volatile stocks — is HYPHENS PHARMA there?
Today HYPHENS PHARMA has the market capitalization of ‪88.12 M‬, it has increased by 7.41% over the last week.
Yes, you can track HYPHENS PHARMA financials in yearly and quarterly reports right on TradingView.
HYPHENS PHARMA is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
1J5 net income for the last half-year is ‪4.78 M‬ SGD, while the previous report showed ‪5.42 M‬ SGD of net income which accounts for −11.78% change. Track more HYPHENS PHARMA financial stats to get the full picture.
Yes, 1J5 dividends are paid annually. The last dividend per share was 0.0086 SGD. As of today, Dividend Yield (TTM)% is 3.02%. Tracking HYPHENS PHARMA dividends might help you take more informed decisions.
HYPHENS PHARMA dividend yield was 5.26% in 2024, and payout ratio reached 45.45%. The year before the numbers were 3.02% and 31.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 25, 2025, the company has 474 employees. See our rating of the largest employees — is HYPHENS PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HYPHENS PHARMA EBITDA is ‪17.59 M‬ SGD, and current EBITDA margin is 8.31%. See more stats in HYPHENS PHARMA financial statements.
Like other stocks, 1J5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYPHENS PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYPHENS PHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYPHENS PHARMA stock shows the neutral signal. See more of HYPHENS PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.